452 related articles for article (PubMed ID: 28775063)
1. Current Management of Hyponatremia in Acute Heart Failure: A Report From the Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (HN Registry).
Dunlap ME; Hauptman PJ; Amin AN; Chase SL; Chiodo JA; Chiong JR; Dasta JF
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28775063
[TBL] [Abstract][Full Text] [Related]
2. Current treatment practice and outcomes. Report of the hyponatremia registry.
Greenberg A; Verbalis JG; Amin AN; Burst VR; Chiodo JA; Chiong JR; Dasta JF; Friend KE; Hauptman PJ; Peri A; Sigal SH
Kidney Int; 2015 Jul; 88(1):167-77. PubMed ID: 25671764
[TBL] [Abstract][Full Text] [Related]
3. Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
Verbalis JG; Greenberg A; Burst V; Haymann JP; Johannsson G; Peri A; Poch E; Chiodo JA; Dave J
Am J Med; 2016 May; 129(5):537.e9-537.e23. PubMed ID: 26584969
[TBL] [Abstract][Full Text] [Related]
4. An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia.
Ramamohan V; Mladsi D; Ronquest N; Kamat S; Boklage S
Hosp Pract (1995); 2017 Aug; 45(3):111-117. PubMed ID: 28449624
[TBL] [Abstract][Full Text] [Related]
5. Economic impact of tolvaptan treatment vs. fluid restriction based on real-world data among hospitalized patients with heart failure and hyponatremia.
Dasta JF; Sundar S; Chase S; Lingohr-Smith M; Lin J
Hosp Pract (1995); 2018 Oct; 46(4):197-202. PubMed ID: 30045645
[TBL] [Abstract][Full Text] [Related]
6. Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study.
Burst V; Grundmann F; Kubacki T; Greenberg A; Rudolf D; Salahudeen A; Verbalis J; Grohé C
Support Care Cancer; 2017 Jul; 25(7):2275-2283. PubMed ID: 28255808
[TBL] [Abstract][Full Text] [Related]
7. Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry.
Sigal SH; Amin A; Chiodo JA; Sanyal A
Can J Gastroenterol Hepatol; 2018; 2018():1579508. PubMed ID: 30363747
[TBL] [Abstract][Full Text] [Related]
8. Thiazide-Associated Hyponatremia, Report of the Hyponatremia Registry: An Observational Multicenter International Study.
Burst V; Grundmann F; Kubacki T; Greenberg A; Becker I; Rudolf D; Verbalis J
Am J Nephrol; 2017; 45(5):420-430. PubMed ID: 28419981
[TBL] [Abstract][Full Text] [Related]
9. Electrolytes: Sodium Disorders.
Braun MM; Mahowald M
FP Essent; 2017 Aug; 459():11-20. PubMed ID: 28806046
[TBL] [Abstract][Full Text] [Related]
10. Use of tolvaptan in patients hospitalized for worsening chronic heart failure with severe hyponatremia: The initial experience at a single-center in Turkey.
Sağ S; Aydın Kaderli A; Yıldız A; Gül BC; Özdemir B; Baran İ; Güllülü S; Aydınlar A; Çavuşoğlu Y
Turk Kardiyol Dern Ars; 2017 Jul; 45(5):415-425. PubMed ID: 28694395
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms, risks, and new treatment options for hyponatremia.
Ghali JK
Cardiology; 2008; 111(3):147-57. PubMed ID: 18434717
[TBL] [Abstract][Full Text] [Related]
12. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.
Nemerovski C; Hutchinson DJ
Clin Ther; 2010 Jun; 32(6):1015-32. PubMed ID: 20637957
[TBL] [Abstract][Full Text] [Related]
14. 'Dos and don'ts' in the management of hyponatremia.
Aylwin S; Burst V; Peri A; Runkle I; Thatcher N
Curr Med Res Opin; 2015; 31(9):1755-61. PubMed ID: 26173050
[TBL] [Abstract][Full Text] [Related]
15. [The treament of hyponatremia secundary to the syndrome of inappropriate antidiuretic hormone secretion].
Runkle I; Villabona C; Navarro A; Pose A; Formiga F; Tejedor A; Poch E;
Med Clin (Barc); 2013 Dec; 141(11):507.e1-507.e10. PubMed ID: 24169317
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia.
Ghali JK; Koren MJ; Taylor JR; Brooks-Asplund E; Fan K; Long WA; Smith N
J Clin Endocrinol Metab; 2006 Jun; 91(6):2145-52. PubMed ID: 16522696
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Management of Hyponatremia: A Review.
Adrogué HJ; Tucker BM; Madias NE
JAMA; 2022 Jul; 328(3):280-291. PubMed ID: 35852524
[TBL] [Abstract][Full Text] [Related]
18. Urine sodium excretion after tolvaptan administration is dependent upon baseline serum sodium levels: a possible explanation for the improvement of hyponatremia with scarce chance of hypernatremia by a vasopressin receptor antagonist.
Imamura T; Kinugawa K; Minatsuki S; Muraoka H; Kato N; Inaba T; Maki H; Hatano M; Yao A; Komuro I
Int Heart J; 2014; 55(2):131-7. PubMed ID: 24632953
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Discharge Hyponatremia in Heart Failure Patients With Normal Admission Sodium (from the ESCAPE Trial).
Omar HR; Charnigo R; Guglin M
Am J Cardiol; 2017 Aug; 120(4):607-615. PubMed ID: 28669488
[TBL] [Abstract][Full Text] [Related]
20. Hyponatremia, heart failure, and the role of tolvaptan.
O'Connell JB; Alemayehu A
Postgrad Med; 2012 Mar; 124(2):29-39. PubMed ID: 22437213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
